Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
By E. Foa, Michael R. Liebowitz, M. Kozak, S. Davies, R. Campeas, Martin E. Franklin, J. Huppert, K. Kjernisted, V. Rowan, Andrew B. Schmidt and 2 more. American Journal of Psychiatry, 2007
884 citations recorded by the source corpus.
Subfields: Clinical Psychology
View Paper: https://www.semanticscholar.org/paper/856d5f068d5e1ee89acab6bb93009dca45052766
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Psychology
- David F. Tolin
- R. Brady
- S. Hannan
- E. Bullmore
- J. Abramowitz
- J. Arch
- Samuel R. Chamberlain
- Naomi A. Fineberg
Citations in the corpus
- Allegiance in Psychotherapy Outcome Research: Separating Association From Bias (2009, methodology): “Findings from studies that have exemplified this approach have been published from comparisons of psychotherapeutic versus pharmacotherapeutic treatments (e.g., Barlow, Gorman, Shear, & Woods, 2000; DeRubeis et al., 2005; Foa et al., 2005; Heimberg et al., 1998), but comparisons of different approac”
- Strategies for Improving Long-Term Outcomes in Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder: Insights From Learning Theory (2014, background): “Numerous controlled and uncontrolled studies conducted in various centers around the world have established ERP (and CBT more broadly) as a highly effective short- and long-term treatment for OCD (e.g., Abramowitz, 1996; Foa et al., 2005).”
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (2002, background): “In one study, ERP was superior to a pill placebo (Foa et al. 2005).”
- Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014, background): “CBT is equivalent or superior to pharmacotherapy [71,658-660].”
- Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. (2008, background): “For example dopamine D2 receptor antagonists have been used with some success to augment the effects of SSRIs in treating OCD (Westenberg et al., 2007).”
- Obsessional Beliefs and Symptoms of Obsessive–Compulsive Disorder in a Clinical Sample (2008, methodology): “Obsessive–Compulsive Inventory-Revised (OCI-R) The OCI-R (Foa et al. 2002) is an 18-item questionnaire based on the earlier 84-item OCI ( Foa et al. 1998 ), and all subscales on the OCI-R correlate highly with their corresponding subscales from the OCI (most are above 0.90).”